Jeffrey M. Dayno sold $774K of Harmony Biosciences (HRMY)

Executed Jan 21 2025, disclosed Jan 23 2025, 2 days later.

Value, as filed

$774K

19,293 sh × $40.13

Executed

Jan 21 2025

the trade date, as filed

Disclosed

Jan 23 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jeffrey M. Dayno PRESIDENT, CEO profile →

Jeffrey M. Dayno (PRESIDENT, CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale, 1 filed past the two-business-day deadline), most often in Harmony Biosciences Holdings, Inc. (HRMY). The largest single filing was $1.0M of HRMY (25,933 sh across 2 lots, as filed), executed Dec 12 2025.

The name

HRMY

Harmony Biosciences Holdings, Inc. HRMY · Healthcare · 21 filings in 24 months ticker →

Healthcare · Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for pati…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jeffrey M. Dayno in HRMY

HRMYSALE Harmony Biosciences Holdings, Inc. $1.0M
25,933 sh across 2 lots
Exec Dec 12 2025
Filed Dec 17 2025 · 5:30 PM ET †